Related Experiment Video
Updated: Jul 12, 2025
Listeria monocytogenes Infection of the Brain
Published on: October 2, 2018
Listeria monocytogenes bacteremia developed during treatment of COVID-19
Jin Yamamoto1, Keitaro Nakamoto2, Teppei Shimasaki3
1Department of Nephrology and Rheumatology Kyorin University School of Medicine Mitaka Tokyo Japan.
Abstract:
Listeria monocytogenes is an important pathogen in older patients and immunosuppressed patients, often causing bacteremia. Complications resulting from infections other than COVID-19 must also be considered during COVID-19 treatment.
Insights
Listeria monocytogenes infections can cause bacteremia, especially in older and immunocompromised individuals. Healthcare providers must consider non-COVID-19 complications during COVID-19 patient treatment.
Area of Science:
- Infectious Diseases
- Bacteriology
- Critical Care Medicine
Background:
- Listeria monocytogenes is a significant bacterial pathogen.
- It disproportionately affects vulnerable populations, including the elderly and immunocompromised.
- Bacteremia is a serious complication of Listeria monocytogenes infection.
Observation:
- COVID-19 treatment requires careful consideration of concurrent health issues.
- Non-COVID-19 infections can complicate patient management.
- Listeria monocytogenes poses a risk to specific patient groups.
Findings:
- Listeria monocytogenes frequently causes bacteremia in susceptible individuals.
- The presence of this pathogen necessitates specific diagnostic and therapeutic approaches.
- Co-infections or other concurrent infections can alter the clinical course.
Implications:
- Clinicians must maintain a high index of suspicion for Listeria monocytogenes in at-risk patients.
- Integrated management strategies are crucial for patients with COVID-19 and other infections.
- Prompt diagnosis and treatment of Listeria monocytogenes can improve outcomes and prevent severe complications.
